Multicenter phase II study of temozolomide and myeloablative chemotherapy with autologous stem cell transplant for newly diagnosed anaplastic oligodendroglioma

BACKGROUND: Anaplastic oligodendroglioma (AO) and anaplastic oligoastrocytoma (AOA) are chemotherapy-sensitive tumors with prolonged survival after radiochemotherapy. We report a prospective trial using induction temozolomide (TMZ) followed by myeloablative high-dose chemotherapy (HDC) with autologo...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Neuro Oncol
Asıl Yazarlar: Thomas, Alissa A, Abrey, Lauren E, Terziev, Robert, Raizer, Jeffrey, Martinez, Nina L, Forsyth, Peter, Paleologos, Nina, Matasar, Matthew, Sauter, Craig S, Moskowitz, Craig, Nimer, Stephen D, DeAngelis, Lisa M, Kaley, Thomas, Grimm, Sean, Louis, David N, Cairncross, J. Gregory, Panageas, Katherine S, Briggs, Samuel, Faivre, Geraldine, Mohile, Nimish A, Mehta, Jayesh, Jonsson, Philip, Chakravarty, Debyani, Gao, Jianjiong, Schultz, Nikolaus, Brennan, Cameron W, Huse, Jason T, Omuro, Antonio
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Oxford University Press 2017
Konular:
Clinical Investigations
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC5596171/
https://ncbi.nlm.nih.gov/pubmed/28472509
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/nox086
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller